These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23040598

  • 21. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Lab; 2005 Jan; 51(3-4):167-72. PubMed ID: 15819172
    [Abstract] [Full Text] [Related]

  • 24. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 25. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 May; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 26. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [NT-proBNP for risk stratification of pulmonary embolism].
    Dores H, Fonseca C, Leal S, Rosário I, Abecasis J, Monge J, Correia MJ, Bronze L, Leitão A, Arroja I, Aleixo A, Silva A.
    Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
    [Abstract] [Full Text] [Related]

  • 30. N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.
    van der Zee PM, Cornel JH, Bholasingh R, Fischer JC, van Straalen JP, De Winter RJ.
    Am J Med; 2011 Oct; 124(10):961-9. PubMed ID: 21962317
    [Abstract] [Full Text] [Related]

  • 31. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.
    N Engl J Med; 2005 Feb 17; 352(7):666-75. PubMed ID: 15716560
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 35. NT-proBNP as a means of triage for the risk of hospitalisation in primary care.
    Adlbrecht C, Neuhold S, Hülsmann M, Strunk G, Ehmsen U, Scholten C, Maurer G, Pacher R.
    Eur J Prev Cardiol; 2012 Feb 03; 19(1):55-61. PubMed ID: 21450621
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May 03; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 38. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK, Ertaş F, Yüksek U, Cakir C, Nazli C, Köseoğlu M, Ergene O.
    Turk Kardiyol Dern Ars; 2009 Jan 03; 37(1):1-8. PubMed ID: 19225247
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.